Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Changing US prostate cancer practices

Nicolas Magne • 2 Jun 2019
ASCO 2019
Prostate Cancer

Nicolas Magne, MD, PhD, of the Lucien Neuwirth Oncology Institute, St-Priest-en-Jarez, France, explains the need for change in US regulations with regards to the use of salvage radiation therapy after prostatectomy. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Nicolas Magne

2:31
Prostate Cancer: radiation with or without androgen-deprivation
Nicolas Magne • 2 Jun 2019
1:55
Radiotherapy: the need for further research
Nicolas Magne • 2 Jun 2019

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
0:45
SYNC-T combination immunotherapy in mCRPC
George Prendergast • 8 Apr 2024
0:40
PSMA PET findings in 225AC-J591-treated patients with mCRPC
Andres Ricaurte-Fajardo • 9 Apr 2024
0:45
Should radioligand therapies be used in earlier settings in prostate cancer?
Andres Ricaurte-Fajardo • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals